Bruce Broussard | 63 Director since: 2021 Current role: Interim Chief Executive Officer, HP (since February 2026) HP board committees: N/A Current public company boards HP Marsh & McLennan Companies, Inc. Prior public company boards KeyCorp Humana Inc. Qualifications: Prior business and other experience President, Chief Executive Officer, and Director (January 2013 July 2024) and Advisor (July 2024 February 2026), Humana, a health insurance company Chief Executive Officer, McKesson Specialty/US Oncology, Inc. (January 2008 December 2011) In 11 years at US Oncology, Inc., which was acquired by McKesson in December 2010, served in a number of senior executive roles, including Chief Financial Officer, President, Chief Executive Officer and Chairman of the Board Other key qualifications Mr. Broussard brings to the Board extensive experience in executive leadership at large global companies, international business management, healthcare and technology-enabled transformation. In addition, as HP s Interim Chief Executive Officer, he provides valuable insight regarding the Company s operations to the Board. From his roles at Humana and US Oncology, Mr. Broussard has significant experience in the healthcare and health technology sectors, including leading Humana through a multi-year digital and analytics transformation. He also provides venture capital and private equity experience, including work with early-stage digital health companies. He also brings public company governance experience as a board member and committee member of other public companies. Skills: Business and management Finance and capital allocation Operations Technology, cybersecurity and science Current or former CEO Government and government affairs Risk management Customer experience Human capital management Strategic transactions; M&A Environmental and societal matters International business and affairs Strategy